How to remove the Corevalve aortic bioprosthesis in a case of surgical aortic valve replacement

Giuseppe Bruschi, Jacopo Oreglia, Federico De Marco, Paola Colombo, Michele Mondino, Roberto Paino, Silvio Klugmann, Luigi Martinelli

Research output: Contribution to journalArticlepeer-review

Abstract

Transcatheter aortic valve implantation has been introduced as a treatment modality applied to high-risk surgery patients with severe symptomatic aortic stenosis, and it has been demonstrated to be an efficient and safe treatment option. Litzler and colleagues reported a case of a bailout of a transcatheter aortic valve implantation because of severe paravalvular leaks, using a 23-mm Edwards-SAPIEN Valve (Edwards Lifesciences, Irvine, CA), with conversion to conventional surgical aortic valve replacement. The authors reported an easy valve removal despite the impaction of the stent in the cusps of the native valve. Thyregod and colleagues reported a surgical valve replacement in a patient with a dysfunctional CoreValve self-expanding aortic valve bioprosthesis 4 months after implantation.

Original languageEnglish
Pages (from-to)329-330
Number of pages2
JournalAnnals of Thoracic Surgery
Volume93
Issue number1
DOIs
Publication statusPublished - Jan 2012

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'How to remove the Corevalve aortic bioprosthesis in a case of surgical aortic valve replacement'. Together they form a unique fingerprint.

Cite this